“fibrogen” Archives

in
Entry Author Date Location
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
Novartis Leads $100M Round for Fibrosis-Focused Pliant Therapeutics 03/03/20 San Francisco
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
With New Results, FibroGen’s Anemia Pill Inches Closer to FDA Review 12/20/18 San Francisco
Biocom Opens New Bay Area Office, Forms Advisory Group 09/18/18 San Diego
Pliant Picks Up $62M to Test Lung, Liver Fibrosis Drug in the Clinic 07/16/18 San Francisco
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On 06/29/18 National
Akebia Merges With Keryx as Anemia Drug Race Nears Finish Line 06/28/18 Boston
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More 08/11/17 National
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits 01/30/17 San Francisco
Akebia Gets $265M From Otsuka to Bankroll Anemia Drug Push 12/20/16 Boston
West Coast Biotech Roundup: Hutch, Gilead, Soon-Shiong IPO & More 07/30/15 San Francisco
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO 11/14/14 San Francisco
FibroGen Obtains $145,800,000 New Financing 11/14/14 San Francisco
West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More 10/30/14 Seattle
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
Bayer, Keeping Tabs on the ‘Hood, to Open Labs For Mission Bay Startups 01/09/12 San Francisco
The Mission Bay Biotech Cluster: Antibodies, RNAi, Biofuels, & More 06/29/10 San Francisco
Acceleron, Bucking Conventional Wisdom, Pushes Ahead Drug For Bone Loss, Anemia 09/11/09 Boston
San Diego’s Palkion Chases Amgen’s Big Market, Joins Race to Develop Oral Anemia Drug 09/01/09 San Diego
Page 1 of 1